3 Metal Fabrication Stocks to Buy as Industry Trends Improve
zacks.com
Want to monitor HALO?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor HALOwe are a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment. our lead proprietary program, investigational drug pegph20, applies a unique approach to targeting solid tumors, potentially providing increased tumor access for co-administered cancer therapies. by breaking down potential barriers to cancer, pegph20 may help make existing treatments more effective by allowing therapies to reach the tumor.